| Bristol N2 |
Wild type |
Wild-type behavior |
Figure 1A–D |
| ZM7978 |
hpIs327 |
Behavior upon RIM ablation |
Figure 6 |
| Calcium imaging |
|---|
| ADS003 |
aeasIs003 |
AIY imaging |
Figures 2E–I, 3A, B
|
| ADS004 |
aeaIs004 |
AFD imaging |
Figure 2C, D |
| ADS027 |
aeaIs003; hpIs471 |
Simultaneous imaging of AIY, AVA, RME, SMDD, SMDV, and RIM |
Figure 2B, E |
| ADS043 |
aeaIs003; yxIs25 |
AIY imaging, upon blockade of AIY chemical transmission |
Figure 3B |
| ADS010 |
aeaIs003; hpIs327 |
AIY imaging, upon ablation of RIM |
Figures 4A, B, 5A, C
|
| ADS014 |
aeaIs003; hpIs321 |
AIY imaging, upon ablation of RIM, AVA, AVE, AVD, and PVC |
Figure 4A |
| ADS026 |
aeaIs003; hpEx3072 |
AIY imaging upon ablation of AVA |
Figure 4A |
| ADS036 |
aeaIs003; hpIs331 |
AIY imaging, upon ablation of AVB |
Figure 4A |
| ADS046 |
aeaIs003; hpIs465 |
AIY imaging, upon ablation of AIB |
Figure 4A, B |
| ADS029 |
aeaEx003; aeaIs003; lite-1(ce314) |
AIY imaging upon optogenetic stimulation of AVB |
Figure 4C |
| ADS031 |
aeaEx005; aeaIs003; lite-1(ce314) |
AIY imaging upon optogenetic stimulation of AVA |
Figure 4E |
| ADS033 |
aeaEx005; aeaIs003; hpIs327; lite-1(ce314) |
AIY imaging, upon RIM ablation and AVA stimulation |
Figure 4E |
| ADS035 |
aeaEx003; aeaIs003; hpIs327; lite-1(ce314) |
AIY imaging, upon RIM ablation and AVB stimulation |
Figure 4C |
| ADS013 |
aeaIs003; kyEx4962 |
AIY imaging, upon disruption of RIM/RIC chemical transmission |
Figure 4—figure supplement 2 |
| ADS006 |
aeaIs003;tdc-1(n3419) |
AIY imaging in tyramine/octopamine synthesis mutant |
Figure 4—figure supplement 2 |
| QW1411 |
aeaIs003; eat-4(ky5) |
AIY imaging in glutamate mutant |
Figure 4—figure supplement 2 |
| QW1175 |
aeaIs003; unc-31(e928) |
AIY imaging in dense core vesicle release mutant |
Figure 4—figure supplement 2 |
| QW1408 |
aeaIs003; cat-1(e1111) |
AIY imaging in biogenic amine transporter mutant |
Figure 4—figure supplement 2 |
